ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

Zacharakis et al.
Nature Medicine
Papers
June 2018
Authors and Affiliates
Nikolaos Zacharakis1, Harshini Chinnasamy1, Mary Black1, Hui Xu1, Yong-Chen Lu1, Zhili Zheng1, Anna Pasetto1, Michelle Langhan1, Thomas Shelton1, Todd Prickett1, Jared Gartner1, Li Jia1, Katarzyna Trebska-McGowan2, Robert P. Somerville1, Paul F. Robbins1, Steven A. Rosenberg1, Stephanie L. Goff1 and Steven A. Feldman1 1Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. 2Department of Surgery, Virginia Commonwealth University School of Medicine, Richmond, VA, USA